Literature DB >> 17966538

Treatment of chronic type B aortic dissection by endovascular grafting in a previously CABG patient. Case report.

M Ugurlucan1, Y Akyol, K Guven, A Poyanli, U Alpagut, I Rozanes, E Dayioglu.   

Abstract

High mortality rates resulting from the surgical treatment of Type B aortic dissections have played an important role in seeking newer alternative therapy modalities for the treatment of the pathology. Especially since the early 1990s, endovascular grafting has become a popular option in the treatment of aortic diseases and with the increasing experience and advances in technology, it has, in recent years, become an alternative approach for the treatment of aortic dissections. In this report, we present the treatment of a 56-year-old male patient with a history of a coronary artery bypass grafting who presented with chronic type B aortic dissection. Endovascular stent graft implantation was performed with a hybrid therapy type of preliminary right subclavian artery to left subclavian artery bypass, followed by endovascular stent graft implantation to the dilated aneurismal segment of the descending aorta, for the treatment of chronic type B aortic dissection. The procedure and the postoperative course were uneventful; moreover, they were very comfortable for the patient undergoing an investigation of the descending aorta, when compared with the conventional surgical treatment modalities.

Entities:  

Mesh:

Year:  2007        PMID: 17966538     DOI: 10.1080/00015458.2007.11680087

Source DB:  PubMed          Journal:  Acta Chir Belg        ISSN: 0001-5458            Impact factor:   1.090


  1 in total

1.  Endovascular Stent Grafting for Aortic Arch Aneurysm in Aortoiliac Occlusive Disease following Aortic Arch Debranching and Aortobifemoral Reconstruction.

Authors:  Didem Melis Oztas; Cagla Canbay; Yilmaz Onal; Metin Onur Beyaz; Omer Ali Sayin; Mehmet Barburoglu; Mehmet Buget; Mesut Yornuk; Aziz Ari; Murat Ugurlucan; Bulent Acunas; Ufuk Alpagut; Enver Dayioglu
Journal:  Case Rep Med       Date:  2017-03-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.